• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定致突变衍生的长链非编码 RNA 基因组不稳定性特征,以促进肝细胞癌的临床转归。

Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma.

机构信息

The First Clinical Medical College, Lanzhou University, Lanzhou City, Gansu Province, China.

The Second Department of Gastrointestinal Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong City, Sichuan Province, China.

出版信息

Comput Math Methods Med. 2021 Nov 11;2021:1205029. doi: 10.1155/2021/1205029. eCollection 2021.

DOI:10.1155/2021/1205029
PMID:34840594
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8613502/
Abstract

BACKGROUND

Accumulating evidence proves that long noncoding RNA (lncRNA) plays a crucial role in maintaining genomic instability. However, it is significantly absent from exploring genomic instability-associated lncRNAs and discovering their clinical significance.

OBJECTIVE

To identify crucial mutator-derived lncRNAs and construct a predictive model for prognosis and genomic instability in hepatocellular carcinoma.

METHODS

First, we constructed a mutator hypothesis-derived calculative framework through uniting the lncRNA expression level and somatic mutation number to screen for genomic instability-associated lncRNA in hepatocellular carcinoma. We then selected mutator-derived lncRNA from the genome instability-associated lncRNA by univariate Cox analysis and Lasso regression analysis. Next, we created a prognosis model with the mutator-derived lncRNA signature. Furthermore, we verified the vital role of the model in the prognosis and genomic instability of hepatocellular carcinoma patients. Finally, we examined the potential relationship between the model and the mutation status of TP53.

RESULTS

In this study, we screened 88 genome instability-associated lncRNAs and built a prognosis model with four mutator-derived lncRNAs. Moreover, the model was an independent predictor of prognosis and an accurate indicator of genomic instability in hepatocellular carcinoma. Finally, the model could catch the TP53 mutation status, and the model was a more effective indicator than the mutation status of TP53 for hepatocellular carcinoma patients.

CONCLUSION

This research adopted a reliable method to analyze the role of lncRNA in genomic instability. Besides, the prognostic model with four mutator-derived lncRNAs is an excellent new indicator of prognosis and genomic instability in hepatocellular carcinoma. In addition, this finding may help clinicians develop therapeutic systems.

摘要

背景

越来越多的证据表明,长链非编码 RNA(lncRNA)在维持基因组不稳定性方面发挥着关键作用。然而,在探索与基因组不稳定性相关的 lncRNA 及其临床意义方面,这方面的研究还明显缺失。

目的

鉴定关键突变衍生的 lncRNA,并构建预测模型,以评估肝细胞癌的预后和基因组不稳定性。

方法

首先,我们通过整合 lncRNA 表达水平和体细胞突变数量,构建了一个突变衍生的计算框架,以筛选肝细胞癌中与基因组不稳定性相关的 lncRNA。然后,我们通过单因素 Cox 分析和 Lasso 回归分析从与基因组不稳定性相关的 lncRNA 中选择突变衍生的 lncRNA。接下来,我们利用突变衍生的 lncRNA 特征构建了一个预后模型。此外,我们验证了该模型在肝细胞癌患者预后和基因组不稳定性中的重要作用。最后,我们检验了该模型与 TP53 突变状态之间的潜在关系。

结果

在本研究中,我们筛选出 88 个与基因组不稳定性相关的 lncRNA,并构建了一个包含四个突变衍生的 lncRNA 的预后模型。此外,该模型是肝细胞癌预后的独立预测因子,也是基因组不稳定性的准确指标。最后,该模型可以捕捉到 TP53 的突变状态,而且作为肝细胞癌患者的指标,该模型比 TP53 突变状态更有效。

结论

本研究采用了一种可靠的方法来分析 lncRNA 在基因组不稳定性中的作用。此外,包含四个突变衍生的 lncRNA 的预后模型是评估肝细胞癌预后和基因组不稳定性的一个优秀的新指标。此外,这一发现可能有助于临床医生开发治疗系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/be17d1544fce/CMMM2021-1205029.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/de4a09635440/CMMM2021-1205029.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/4121782227c3/CMMM2021-1205029.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/df3f7a5376a7/CMMM2021-1205029.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/d3b7415028d3/CMMM2021-1205029.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/076da442a630/CMMM2021-1205029.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/ff993ca8c1db/CMMM2021-1205029.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/067e02324683/CMMM2021-1205029.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/1d4b1239668d/CMMM2021-1205029.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/bb2861b1ee44/CMMM2021-1205029.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/be17d1544fce/CMMM2021-1205029.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/de4a09635440/CMMM2021-1205029.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/4121782227c3/CMMM2021-1205029.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/df3f7a5376a7/CMMM2021-1205029.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/d3b7415028d3/CMMM2021-1205029.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/076da442a630/CMMM2021-1205029.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/ff993ca8c1db/CMMM2021-1205029.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/067e02324683/CMMM2021-1205029.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/1d4b1239668d/CMMM2021-1205029.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/bb2861b1ee44/CMMM2021-1205029.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e4/8613502/be17d1544fce/CMMM2021-1205029.010.jpg

相似文献

1
Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma.鉴定致突变衍生的长链非编码 RNA 基因组不稳定性特征,以促进肝细胞癌的临床转归。
Comput Math Methods Med. 2021 Nov 11;2021:1205029. doi: 10.1155/2021/1205029. eCollection 2021.
2
Construction of a genome instability-derived lncRNA-based risk scoring system for the prognosis of hepatocellular carcinoma.构建基于基因组不稳定性的 lncRNA 风险评分系统用于预测肝细胞癌的预后。
Aging (Albany NY). 2021 Nov 18;13(22):24621-24639. doi: 10.18632/aging.203698.
3
A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma.一个源于体细胞突变的 LncRNA 基因组不稳定性特征可预测肝细胞癌的预后和肿瘤微环境免疫特征。
Hepatol Int. 2022 Oct;16(5):1220-1233. doi: 10.1007/s12072-022-10375-y. Epub 2022 Aug 10.
4
Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.长链非编码 RNA 标志物预测肝细胞癌无复发生存率。
World J Gastroenterol. 2019 Jan 14;25(2):220-232. doi: 10.3748/wjg.v25.i2.220.
5
Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.鉴定和验证一种新型的八个突变衍生的长非编码 RNA 特征作为低级别胶质瘤基因组不稳定性的预后生物标志物。
Aging (Albany NY). 2021 Jun 3;13(11):15164-15192. doi: 10.18632/aging.203079.
6
Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.鉴定五个长链非编码 RNA 标志物以改善肝细胞癌患者的预后预测。
World J Gastroenterol. 2018 Aug 14;24(30):3426-3439. doi: 10.3748/wjg.v24.i30.3426.
7
Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer.基于突变子衍生的长链非编码 RNA 基因组不稳定性特征的计算鉴定,以改善癌症的临床预后:以乳腺癌为例的研究。
Brief Bioinform. 2020 Sep 25;21(5):1742-1755. doi: 10.1093/bib/bbz118.
8
Construction of a Novel LncRNA Signature Related to Genomic Instability to Predict the Prognosis and Immune Activity of Patients With Hepatocellular Carcinoma.构建与基因组不稳定性相关的新型长链非编码 RNA 标志物,预测肝细胞癌患者的预后和免疫活性。
Front Immunol. 2022 Apr 8;13:856186. doi: 10.3389/fimmu.2022.856186. eCollection 2022.
9
Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.鉴定 m6A 甲基转移酶相关的长链非编码 RNA 特征,以预测肝细胞癌患者的免疫治疗和预后。
Biosci Rep. 2021 Jun 25;41(6). doi: 10.1042/BSR20210760.
10
Identification of Long Noncoding RNA Biomarkers for Hepatocellular Carcinoma Using Single-Sample Networks.基于单样本网络的肝细胞癌长非编码 RNA 标志物的鉴定。
Biomed Res Int. 2020 Nov 14;2020:8579651. doi: 10.1155/2020/8579651. eCollection 2020.

引用本文的文献

1
Long non-coding RNA-based single and combination independent prognostic biomarkers for hepatocellular carcinoma.基于长链非编码RNA的肝细胞癌单因素及联合独立预后生物标志物
Discov Oncol. 2025 Sep 2;16(1):1674. doi: 10.1007/s12672-025-03309-1.
2
A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer.一种与基因组不稳定性相关的 lncRNA 模型,可预测乳腺癌的预后和免疫检查点抑制剂疗效。
Front Immunol. 2022 Aug 5;13:929846. doi: 10.3389/fimmu.2022.929846. eCollection 2022.
3
Ogt Demonstrated Conspicuous Clinical Significance in Cancers, from Pan-Cancer to Small-Cell Lung Cancer.

本文引用的文献

1
Identification of an 11-lncRNA signature with high performance for predicting the prognosis of hepatocellular carcinoma using bioinformatics analysis.基于生物信息学分析鉴定出一个具有高预测性能的 11-lncRNA 标志物,用于预测肝细胞癌的预后。
Medicine (Baltimore). 2021 Feb 5;100(5):e23749. doi: 10.1097/MD.0000000000023749.
2
The progression of pancreatic cancer cells is promoted by a long non-coding RNA LUCAT1 by activating AKT phosphorylation.长链非编码 RNA LUCAT1 通过激活 AKT 磷酸化促进胰腺癌细胞的进展。
Eur Rev Med Pharmacol Sci. 2021 Jan;25(2):738-748. doi: 10.26355/eurrev_202101_24635.
3
Long noncoding LUCAT1 promotes cisplatin resistance of non-small cell lung cancer by promoting IGF-2.
Ogt在癌症中显示出显著的临床意义,从泛癌到小细胞肺癌。
J Oncol. 2022 Mar 21;2022:2010341. doi: 10.1155/2022/2010341. eCollection 2022.
长链非编码RNA LUCAT1通过促进IGF-2表达来增强非小细胞肺癌对顺铂的耐药性。
Eur Rev Med Pharmacol Sci. 2021 Jan;25(2):567. doi: 10.26355/eurrev_202101_24593.
4
Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.作者更正:TP53等位基因状态对骨髓增生异常综合征基因组稳定性、临床表现及预后的影响
Nat Med. 2021 Mar;27(3):562. doi: 10.1038/s41591-021-01253-5.
5
N6-methyladenosine (m6A)-mediated messenger RNA signatures and the tumor immune microenvironment can predict the prognosis of hepatocellular carcinoma.N6-甲基腺苷(m6A)介导的信使核糖核酸特征与肿瘤免疫微环境可预测肝细胞癌的预后。
Ann Transl Med. 2021 Jan;9(1):59. doi: 10.21037/atm-20-7396.
6
MiR-133b inhibits colorectal cancer metastasis via lncRNA-LUCAT1.miR-133b 通过 lncRNA-LUCAT1 抑制结直肠癌转移。
Future Oncol. 2021 Mar;17(9):1013-1023. doi: 10.2217/fon-2020-0420. Epub 2021 Feb 5.
7
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
8
Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma.鉴定一种与自噬相关的五个长链非编码RNA特征作为肝细胞癌的新型预后生物标志物
Front Mol Biosci. 2021 Jan 11;7:611626. doi: 10.3389/fmolb.2020.611626. eCollection 2020.
9
STAT1-induced regulation of lncRNA ZFPM2-AS1 predicts poor prognosis and contributes to hepatocellular carcinoma progression via the miR-653/GOLM1 axis.STAT1 诱导的长链非编码 RNA ZFPM2-AS1 调控预测肝癌不良预后并通过 miR-653/GOLM1 轴促进肝癌进展。
Cell Death Dis. 2021 Jan 4;12(1):31. doi: 10.1038/s41419-020-03300-4.
10
ZFPM2-AS1 facilitates cell proliferation and migration in cutaneous malignant melanoma through modulating miR-650/NOTCH1 signaling.ZFPM2-AS1 通过调节 miR-650/NOTCH1 信号通路促进皮肤恶性黑色素瘤细胞的增殖和迁移。
Dermatol Ther. 2021 Mar;34(2):e14751. doi: 10.1111/dth.14751. Epub 2021 Jan 23.